Clinical Trial Update: A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL [Phase 2]

View source ↗

Summary

Phase 2 feasibility trial evaluating co-administration of combination antiretroviral therapy (cART) with R-EPOCH chemotherapy for AIDS-related lymphoma has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Lymphoma
• HIV Infection

Drugs mentioned

• Combination antiretroviral therapy (cART) (Antiretroviral therapy)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Ontario Clinical Oncology Group (OCOG) | Conditions: Lymphoma, AIDS Related, HIV Infections | Phase 2 | Status: COMPLETED